Orange County Research Institute

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Obstructive sleep apnoea4 trials
• Osteoarthritis4 trials
• Atopic dermatitis (eczema)1 trial
• High blood pressure1 trial

Phase

• Phase 38 trials
• Phase 21 trial

Status

• Completed7 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Apnimed3 trials
• Grünenthal GmbH2 trials
• Eli Lilly and Company1 trial
• Mineralys Therapeutics Inc.1 trial
• Paradigm Biopharmaceuticals Ltd.1 trial
• and 1 more

Running trials

• Active, not recruiting

  A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.

  NCT06917404· Phase 3· Paradigm Biopharmaceuticals Ltd.· Source

• Enrolling by invitation

  Continuation Protocol for Obstructive Sleep Apnea (OSA)

  NCT06566820· Phase 3· Apnimed· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obstructive sleep apnoea1 recruiting

Closed trials

• Completed

  A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension

  NCT06785454· Phase 2· Mineralys Therapeutics Inc.· Source

• Completed

  Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

  NCT05813275· Phase 3· Apnimed· Source

• Completed

  Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

  NCT05811247· Phase 3· Apnimed· Source

• Completed

  Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee

  NCT05449132· Phase 3· Grünenthal GmbH· Source

• Completed

  Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee

  NCT05377489· Phase 3· Grünenthal GmbH· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Knee Pain

  NCT03081806· Phase 3· Techfields Pharma Co. Ltd· Source

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source